by Scott Larrivee | Apr 20, 2023 | News
NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...
by Scott Larrivee | Apr 17, 2023 | News, Utah
New domestic supply source to help address critical shortage of medical radioisotopes Proprietary platform will be capable of generating up to 12 different rare isotopes simultaneously WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping...
by Scott Larrivee | Mar 27, 2023 | News
NEW YORK and VALENCIA, Calif. – March 27, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will present and participate in a panel discussion at Jefferies Inaugural Radiopharma Innovation Summit in New York...
by Scott Larrivee | Jan 30, 2023 | Industry News
Jan. 30, 2023 – Health Imaging reports on a new case study published indicating that radioisotope supply issues are delaying prostate cancer treatments using 177Lu-PSMA-617, commonly known as Pluvicto. The health care news source writes: Following its [2022 FDA]...
by Scott Larrivee | Jan 11, 2023 | Industry News
Jan. 11, 2023 – Citing aging infrastructure and anticipated future demand, the Welsh government is taking action to establish a stable supply of medical radioisotopes for citizens of the United Kingdom. World Nuclear News reports: The Welsh government says that, as...
